Pancreatic cancer is a dismal disease. The 5-years overall survival ranges from 1% to 5%. Surgery is the only curative treatment available. Survival of selected patients with small lesion (< 2 cm) confined to the pancreas is improved to 19-41%. Presently the major effort is on studies of the cancer development phenomena to improve detection of patients with early lesions. The analysis of oncogene and tumor-suppressor gene activation may enable us to better define and cure this disease. Molecular genetic new tecnquiques performed on pancreatic juice, duodenal juice and stool, probably are the most promising new approach for early diagnosis of pancreatic cancer. This could be the right path to diagnose pancreatic malignant lesions at a curable stage, and to discriminate patients with a more favourable prognosis candidates to be submitted to adjuvant therapy with a curative intent, and also to discriminate real pancreatic cancer from patients with chronic pancreatitis.
Le anomalie genetiche del carcinoma pancreatico e le applicazioni cliniche [Genetic anomalies of pancreatic carcinoma and clinical applications] / Pantalone, D; Pelo, E; Minuti, B; Mazza, E; Nesi, G; Falchini, M; Ragionieri, I; Pantalone, F; Torricelli, F. - In: LA CLINICA TERAPEUTICA. - ISSN 0009-9074. - STAMPA. - 152:(2001), pp. 189-196.
Le anomalie genetiche del carcinoma pancreatico e le applicazioni cliniche [Genetic anomalies of pancreatic carcinoma and clinical applications]
PANTALONE, DESIRE'
Writing – Original Draft Preparation
;PELO, ELISABETTAWriting – Review & Editing
;MAZZA, ELENAInvestigation
;FALCHINI, MASSIMOInvestigation
;TORRICELLI, FRANCESCA
2001
Abstract
Pancreatic cancer is a dismal disease. The 5-years overall survival ranges from 1% to 5%. Surgery is the only curative treatment available. Survival of selected patients with small lesion (< 2 cm) confined to the pancreas is improved to 19-41%. Presently the major effort is on studies of the cancer development phenomena to improve detection of patients with early lesions. The analysis of oncogene and tumor-suppressor gene activation may enable us to better define and cure this disease. Molecular genetic new tecnquiques performed on pancreatic juice, duodenal juice and stool, probably are the most promising new approach for early diagnosis of pancreatic cancer. This could be the right path to diagnose pancreatic malignant lesions at a curable stage, and to discriminate patients with a more favourable prognosis candidates to be submitted to adjuvant therapy with a curative intent, and also to discriminate real pancreatic cancer from patients with chronic pancreatitis.File | Dimensione | Formato | |
---|---|---|---|
Anomalie genetiche pancreas 2001_0001.pdf
accesso aperto
Descrizione: Studio sulle alterazioni genetiche specifiche per il cancro del pancreas , nella bile dei pazienti sottoposti ad detensione percultanea delle vie biliari
Tipologia:
Pdf editoriale (Version of record)
Licenza:
Open Access
Dimensione
4.39 MB
Formato
Adobe PDF
|
4.39 MB | Adobe PDF |
I documenti in FLORE sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.